Seeking Clues to Northrop Grumman (NOC) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Werte in diesem Artikel
Wall Street analysts forecast that Northrop Grumman (NOC) will report quarterly earnings of $6.75 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $10.11 billion, exhibiting a decrease of 1.1% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.That said, let's delve into the average estimates of some Northrop Grumman metrics that Wall Street analysts commonly model and monitor.It is projected by analysts that the 'Sales- Mission Systems' will reach $2.90 billion. The estimate points to a change of +4.8% from the year-ago quarter.Analysts expect 'Sales- Aeronautics Systems' to come in at $3.15 billion. The estimate indicates a change of +6.4% from the prior-year quarter.Based on the collective assessment of analysts, 'Sales- Space Systems' should arrive at $2.70 billion. The estimate suggests a change of -24.3% year over year.Analysts forecast 'Sales- Defense Systems' to reach $1.86 billion. The estimate indicates a change of +23% from the prior-year quarter.Analysts predict that the 'Operating income (loss)- Defense Systems' will reach $183.70 million. Compared to the present estimate, the company reported $204.00 million in the same quarter last year.According to the collective judgment of analysts, 'Operating income (loss)- Mission Systems' should come in at $421.42 million. Compared to the present estimate, the company reported $361.00 million in the same quarter last year.Analysts' assessment points toward 'Operating income (loss)- Space Systems' reaching $283.42 million. The estimate is in contrast to the year-ago figure of $324.00 million.The combined assessment of analysts suggests that 'Operating income (loss)- Aeronautics Systems' will likely reach $301.27 million. Compared to the present estimate, the company reported $295.00 million in the same quarter last year.The consensus among analysts is that 'Segment operating income adjustment- FAS/CAS operating adjustment' will reach $65.27 million. The estimate compares to the year-ago value of $6.00 million. View all Key Company Metrics for Northrop Grumman here>>> Shares of Northrop Grumman have demonstrated returns of +5.1% over the past month compared to the Zacks S&P 500 composite's +4.2% change. With a Zacks Rank #4 (Sell), NOC is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Northrop Grumman Corporation (NOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Northrop Grumman und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Northrop Grumman
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Northrop Grumman Corp.
Analysen zu Northrop Grumman Corp.
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Northrop Grumman Overweight | Barclays Capital | |
26.10.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
12.01.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
10.11.2016 | Northrop Grumman Overweight | Barclays Capital | |
06.10.2016 | Northrop Grumman Outperform | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
29.03.2018 | Northrop Grumman Overweight | Barclays Capital | |
26.10.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
12.01.2017 | Northrop Grumman Outperform | RBC Capital Markets | |
10.11.2016 | Northrop Grumman Overweight | Barclays Capital | |
06.10.2016 | Northrop Grumman Outperform | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
19.05.2016 | Northrop Grumman Sector Perform | RBC Capital Markets | |
02.05.2016 | Northrop Grumman Equal Weight | Barclays Capital | |
30.04.2015 | Northrop Grumman Neutral | UBS AG | |
12.02.2015 | Northrop Grumman Equal Weight | Barclays Capital | |
19.10.2012 | Northrop Grumman perform | Oppenheimer & Co. Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
13.09.2012 | Northrop Grumman sell | UBS AG | |
14.06.2006 | Update Northrop Grumman Corp.: Underperform | Goldman Sachs |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen